⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13902383 | 1.00 | — | — | |
| SCHEMBL2055568 | 1.00 | — | — | |
| SCHEMBL17040309 | 1.00 | — | — | |
| SCHEMBL2055570 | 1.00 | — | — | |
| SCHEMBL3089367 | 0.78 | — | — | |
| SCHEMBL625447 | 0.78 | — | — | |
| SCHEMBL3089364 | 0.78 | — | — | |
| SCHEMBL14490647 | 0.78 | — | — | |
| SCHEMBL19448335 | 0.78 | — | — | |
| SCHEMBL2801704 | 0.78 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 161 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250285817-A1 | Ultracapacitor for Use in a Solder Reflow Process | KYOCERA AVX Components Corporation | 2025-09-11 | — | — | US | disclosed |
| US-20250132104-A1 | Ultracapacitor Including a Sulfur-Based Electrolyte System | KYOCERA AVX Components Corporation | 2025-04-24 | — | — | US | disclosed |
| WO-2025085753-A1 | ULTRACAPACITOR INCLUDING A SULFUR-BASED ELECTROLYTE SYSTEM | KYOCERA AVX Components Corporation (US) | 2025-04-24 | — | — | WO | disclosed |
| EP-3541894-B1 | PROCESS FOR CONVERSION OF CRUDE OIL TO PETROCHEMICALS AND FUEL PRODUCTS INTEGRATING STEAM CRACKING, FLUID CATALYTIC CRACKING, AND CONVERSION OF NAPHTHA INTO CHEMICAL RICH REFORMATE | SAUDI ARABIAN OIL CO (SA) | 2024-01-10 | — | — | EP | disclosed |
| EP-3541896-B1 | PROCESS FOR CONVERSION OF CRUDE OIL TO PETROCHEMICALS AND FUEL PRODUCTS INTEGRATING VACUUM GAS OIL HYDROCRACKING AND STEAM CRACKING | SAUDI ARABIAN OIL CO (SA) | 2023-12-27 | — | — | EP | disclosed |
| US-11760941-B2 | Catalytic pre-reforming process to convert paraffinic hydrocarbons | SAUDI ARABIAN OIL COMPANY (SA) | 2023-09-19 | — | — | US | disclosed |
| EP-3541897-B1 | PROCESS FOR CONVERSION OF CRUDE OIL TO PETROCHEMICALS AND FUEL PRODUCTS INTEGRATING VACUUM RESIDUE HYDROPROCESSING | SAUDI ARABIAN OIL CO (SA) | 2023-05-03 | — | — | EP | disclosed |
| EP-3541899-B1 | PROCESS FOR CONVERSION OF CRUDE OIL TO PETROCHEMICALS AND FUEL PRODUCTS INTEGRATING STEAM CRACKING AND FLUID CATALYTIC CRACKING | SAUDI ARABIAN OIL CO (SA) | 2023-04-12 | — | — | EP | disclosed |
| WO-2022155579-A1 | PROCESS FOR FLUIDIZED CATALYTIC CRACKING OF DISULFIDE OIL TO PRODUCE BTX | SAUDI ARABIAN OIL COMPANY (SA) | 2022-07-21 | — | — | WO | disclosed |
| US-20220220395-A1 | CATALYTIC PRE-REFORMING PROCESS TO CONVERT PARAFFINIC HYDROCARBONS | SAUDI ARABIAN OIL COMPANY (SA) | 2022-07-14 | — | — | US | disclosed |
| US-7723341-B2 | Dihydrothienopyrimidines, suitable for the treatment of respiratory, gastrointestinal, inflammatory, nervous system disorders and/or cancer | BOEHRINGER INGELHEIM INTERNATIONAL GMBH | 2010-05-25 | — | — | US | disclosed |
| US-20090186875-A1 | Dihydrothienopyrimidines, suitable for the treatment of respiratory, gastrointestinal, inflammatory, nervous system disorders and/or cancer | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2009-07-23 | — | — | US | disclosed |
| EP-1874781-B1 | DIHYDROTHIENOPYRIMIDINES FOR THE TREATMENT OF INFLAMMATORY DISEASES | BOEHRINGER INGELHEIM INT (DE) | 2009-06-24 | — | — | EP | disclosed |
| EP-2060575-A1 | Dihydrothienopyrimidines and their use in treating inflammatory diseases | Boehringer Ingelheim International GmbH (DE) | 2009-05-20 | — | — | EP | disclosed |
| US-20090105166-A1 | Novel lapachone compounds and methods of use thereof | ARQULE, INC. | 2009-04-23 | — | — | US | disclosed |
| US-7511045-B2 | Dihydrothienopyrimidines; gastrointestinal disorders; cancer | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2009-03-31 | — | — | US | disclosed |
| US-20070259846-A1 | Dihydrothienopyrimidines; gastrointestinal disorders; cancer | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2007-11-08 | — | — | US | disclosed |
| WO-2006111549-A1 | DIHYDROTHIENOPYRIMIDINES FOR THE TREATMENT OF INFLAMMATORY DISEASES | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2006-10-26 | — | — | WO | disclosed |
| US-6683081-B2 | INHIBITORS OF CYCLIC GUANOSINE 3',5'-MONOPHOPHATE METABOLIZING PHOSPHODIESTERASES | BAYER AKTIENGESELLSCHAFT (DE) | 2004-01-27 | — | — | US | disclosed |
| US-6683081-B2 | INHIBITORS OF CYCLIC GUANOSINE 3',5'-MONOPHOPHATE METABOLIZING PHOSPHODIESTERASES | BAYER AKTIENGESELLSCHAFT (DE) | 2004-01-27 | — | — | US | disclosed |